Full Coverage

Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American...

                   
drugs.com
May 22, 2008
        
Story Timeline:  198 days

MILAN, Italy, May 21, 2008 - BioXell S.p.A. (SWX: BXLN) today presents the data from its successful Phase IIb trial of Elocalcitol in BPH (Benign Prostatic Hyperplasia) in a podium presentation at the American Urological Association Annual... ... MILAN, Italy, May 21,... [read full story]                    

Add Comment
Latest article on this story:

DJ HUGIN NEWS/Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of...

 rss-nachrichten.de May 21, 2008
First article on this story:

Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American...

 klamm.de May 21, 2008
Selected publications with coverage of this story:
drugs.com rss-nachrichten.de euroinvestor.co.uk ad-hoc-news.de klamm.de
RELATED
Found 3 documents:
                   

DJ HUGIN NEWS/Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of...

rss-nachrichten.de
May 21, 2008
        

Corporate news announcement processed and transmitted by Hugin ASA. The issuer is solely responsible for the content of this announcement. =--------------------------------------------------------------------- =------------- Milan, Italy, May 21, 2008 - BioXell S.p.A.

                   

Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American...

ad-hoc-news.de
May 21, 2008
        

Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American Urological Association Corporate news announcement processed and transmitted by Hugin ASA. Corporate News announcement processed and transmitted by Hugin ASA.The issuer is solely responsible for the...

                   

Data from Phase IIb trial of Elocalcitol in BPH presented at the annual meeting of the American...

klamm.de
May 21, 2008
        

Corporate news announcement processed and transmitted by Hugin ASA. BioXell S.p.A. (SWX: BXLN) today presents the data from its successful Phase IIb trial of Elocalcitol in BPH (Benign Prostatic Hyperplasia) in a podium presentation at the American Urological Association Annual Meeting (AUA) in...